Requires Adobe Acrobat ReaderRequires Adobe Acrobat Reader| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | ||
| Functioning Graft at Discharge | 206 | 278 | 287 | 336 | 315 | 380 | 306 | 255 | 240 | 193 | |
| With Immunosuppression Info | 203 | 277 | 286 | 335 | 312 | 375 | 303 | 249 | 230 | 192 | |
| Corticosteroids | Any in Category | 90.1% | 95.7% | 93.4% | 89.9% | 80.8% | 74.7% | 66.7% | 63.9% | 57.8% | 59.9% |
| Steroids | 90.1% | 95.7% | 93.4% | 89.9% | 80.8% | 74.7% | 66.7% | 63.9% | 57.8% | 59.9% | |
| Cyclosporine | Any in Category | 14.3% | 13.7% | 9.8% | 11.3% | 8.3% | 8.3% | 6.6% | 5.6% | 4.8% | 3.6% |
| Sandimmmune | 2.5% | 2.2% | 0.7% | 0.6% | 0.3% | 0.5% | 0.3% | 0.0% | 1.7% | 0.0% | |
| Neoral | 11.3% | 11.6% | 8.0% | 9.0% | 6.1% | 5.6% | 5.9% | 5.2% | 3.0% | 3.1% | |
| Gengraf | 0.5% | 0.0% | 1.0% | 1.8% | 1.9% | 2.1% | 0.3% | 0.4% | 0.0% | 0.5% | |
| Tacrolimus | Any in Category | 83.3% | 85.2% | 90.6% | 86.3% | 80.8% | 79.7% | 85.5% | 92.0% | 93.0% | 92.7% |
| Tacrolimus | 83.3% | 85.2% | 90.6% | 86.3% | 80.8% | 79.7% | 85.5% | 92.0% | 93.0% | 92.7% | |
| Antimetabolites | Any in Category | 85.2% | 82.3% | 75.5% | 74.3% | 85.6% | 80.3% | 83.8% | 84.3% | 94.3% | 93.8% |
| Mycophenolate Mofetil | 81.8% | 80.5% | 74.1% | 74.0% | 84.9% | 78.9% | 79.5% | 74.3% | 83.9% | 79.2% | |
| Mycophenolate Sodium | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% | 3.3% | 9.6% | 9.1% | 13.0% | |
| Azathioprine | 3.4% | 1.8% | 1.4% | 0.3% | 0.6% | 0.3% | 1.0% | 0.4% | 1.3% | 1.0% | |
| Leflunomide | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% | |
| mTOR Inhibitors | Any in Category | 1.5% | 8.3% | 22.0% | 19.4% | 14.7% | 16.3% | 13.9% | 15.7% | 7.8% | 7.8% |
| Sirolimus | 1.5% | 8.3% | 22.0% | 19.4% | 14.7% | 16.3% | 13.9% | 15.7% | 7.8% | 7.8% | |
| Everolimus | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Requires Adobe Acrobat Reader